{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:37:44Z","timestamp":1785314264778,"version":"3.55.0"},"reference-count":89,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21772101"],"award-info":[{"award-number":["21772101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Eukaryotic elongation factor 1A (eEF1A), the second most abundant intracellular protein, not only plays a key role in peptide elongation, but is also capable of numerous moonlighting functions. Within malignant cells, eEF1A is by no means a neutral bystander but instead actively participates in oncogenic transformations via a myriad of molecular pathways. Thus far, a broad range of small-molecule inhibitors have been identified, which, despite their structural diversity, suppress tumor growth by targeting eEF1A. Interestingly, just as eEF1A enables its oncogenic potential far beyond boosting protein translation, these targeted agents disrupt this oncoprotein via multiple axes distinct from mere protein synthesis inhibition. Whereas the oncogenic mechanisms of eEF1A has been well documented, there lacks a systemic survey of the eEF1A-targeting agents in terms of their mechanisms. Accordingly, the present work aims to examine their multifaceted modes of action more than just blocking protein synthesis. By unveiling these insights, our deepened knowledge of these eEF1A-binding inhibitors will inform the development of future eEF1A-targeted drugs for cancer treatment.<\/jats:p>","DOI":"10.3390\/ijms26157331","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T16:16:10Z","timestamp":1753805770000},"page":"7331","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Eukaryotic Elongation Factor 1A: How Small-Molecule Inhibitors Suppress Tumor Growth via Diverse Pathways"],"prefix":"10.3390","volume":"26","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmei","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-1686","authenticated-orcid":false,"given":"Changliang","family":"Shan","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4292-4263","authenticated-orcid":false,"given":"Weicheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","volume":"4","author":"Futreal","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lui, K., Cheung, K.-K., Ng, W.W.-M., Wang, Y., Au, D.W.H., and Cho, W.C. (2024). The Impact of Genetic Mutations on the Efficacy of Immunotherapies in Lung Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252211954"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1300","article-title":"Cancer as a robust system: Implications for anticancer therapy","volume":"4","author":"Kitano","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Krol, K., Mazur, A., Stachyra-Strawa, P., and Grzybowska-Szatkowska, L. (2023). Non-Small Cell Lung Cancer Treatment with Molecularly Targeted Therapy and Concurrent Radiotherapy-A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065858"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wang, C., Yao, S., Zhang, T., Sun, X., Bai, C., and Zhou, P. (2024). RNA N6-Methyladenosine Modification in DNA Damage Response and Cancer Radiotherapy. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202401.0963.v1"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mark, C., Lee, J.S., Cui, X., and Yuan, Y. (2023). Antibody-drug conjugates in breast cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241813726"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.seminoncol.2005.08.002","article-title":"Toxin conjugate therapy of cancer","volume":"32","author":"Wong","year":"2005","journal-title":"Semin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chiec, L., and Bruno, D.S. (2024). Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910861"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ohishi, T., Kaneko, M.K., Yoshida, Y., Takashima, A., Kato, Y., and Kawada, M. (2023). Current Targeted Therapy for Metastatic Colorectal Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021702"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chu, J., and Pelletier, J. (2018). Therapeutic opportunities in eukaryotic translation. Cold Spring Harbor Perspect. Biol., 10.","DOI":"10.1101\/cshperspect.a032995"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1021\/acs.jmedchem.0c01746","article-title":"Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents","volume":"64","author":"Fan","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, H., Cai, J., Yu, S., Sun, B., and Zhang, W. (2023). Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065184"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0079-6603(08)60889-2","article-title":"Eukaryotic translation elongation factor 1\u03b1: Structure, expression, functions, and possible role in aminoacyl-tRNA channeling","volume":"60","author":"Negrutskii","year":"1998","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Soares, D.C., Barlow, P.N., Newbery, H.J., Porteous, D.J., and Abbott, C.M. (2009). Structural models of human eEF1A1 and eEF1A2 reveal two distinct surface clusters of sequence variation and potential differences in phosphorylation. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006315"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mills, A., and Gago, F. (2021). On the Need to Tell Apart Fraternal Twins eEF1A1 and eEF1A2, and Their Respective Outfits. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136973"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/nar\/26.8.1884","article-title":"The elongation factor 1 A-2 isoform from rabbit: Cloning of the cDNA and characterization of the protein","volume":"26","author":"Kahns","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cbic.202000516","article-title":"Structural Cues for Understanding eEF1A2 Moonlighting","volume":"22","author":"Carriles","year":"2021","journal-title":"ChemBioChem"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21209","DOI":"10.1074\/jbc.R110.113795","article-title":"eEF1A: Thinking outside the ribosome","volume":"285","author":"Mateyak","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/wrna.1118","article-title":"The many roles of the eukaryotic elongation factor 1 complex","volume":"3","author":"Sasikumar","year":"2012","journal-title":"WIREs RNA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00109-003-0461-8","article-title":"Not just for housekeeping: Protein initiation and elongation factors in cell growth and tumorigenesis","volume":"81","author":"Thornton","year":"2003","journal-title":"J. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00726-004-0088-2","article-title":"The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: Review article","volume":"26","author":"Lamberti","year":"2004","journal-title":"Amino Acids"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Abbas, W., Kumar, A., and Herbein, G. (2015). The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections. Front. Oncol., 5.","DOI":"10.3389\/fonc.2015.00075"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng904","article-title":"Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer","volume":"31","author":"Anand","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107195","DOI":"10.1016\/j.phrs.2024.107195","article-title":"The eEF1A protein in cancer: Clinical significance, oncogenic mechanisms, and targeted therapeutic strategies","volume":"204","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/pin.13457","article-title":"High expression of eukaryotic elongation factor 1-alpha-2 in lung adenocarcinoma is associated with poor prognosis","volume":"74","author":"Yamato","year":"2024","journal-title":"Pathol. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-024-03765-0","article-title":"DNA methylation profiling identifies epigenetic signatures of early gastric cancer","volume":"484","author":"Shi","year":"2024","journal-title":"Virchows Arch."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00179597","article-title":"The first marine compound entering clinical trials as an antineoplastic agent","volume":"4","author":"Chun","year":"1986","journal-title":"Investig. New Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2217\/fon-2018-0492","article-title":"Plitidepsin: A potential new treatment for relapsed\/refractory multiple myeloma","volume":"15","author":"Leisch","year":"2019","journal-title":"Future Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bph.14876","article-title":"Enriching cancer pharmacology with drugs of marine origin","volume":"177","author":"Jimenez","year":"2020","journal-title":"Brit. J. Pharmacol."},{"key":"ref_32","unstructured":"(2025, July 01). Metarrestin (ML-246) in Subjects with Metastatic Solid Tumors (Clinical trial ID: NCT04222413), Available online: www.clinicaltrials.gov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1039\/c2np00065b","article-title":"Didemnins, tamandarins and related natural products","volume":"29","author":"Lee","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0040-4039(97)00170-6","article-title":"Novel triene-ansamycins, cytotrienins A and B, inducing apoptosis on human leukemia HL-60 cells","volume":"38","author":"Zhang","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2011.05.072","article-title":"Cytotrienin A, a translation inhibitor that induces ectodomain shedding of TNF receptor 1 via activation of ERK and p38 MAP kinase","volume":"667","author":"Yamada","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/acs.orglett.1c04032","article-title":"Ansafurantrienins, Unprecedented Ansatrienin Derivatives Formed via Photocatalytic Intramolecular [3+ 2] Oxidative Cycloaddition","volume":"24","author":"Li","year":"2022","journal-title":"Org. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1096\/fj.10-162263","article-title":"Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas","volume":"24","author":"Hutton","year":"2010","journal-title":"FASEB J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1021\/jm101440r","article-title":"Novel flavonoids with antiproliferative activities against breast cancer cells","volume":"54","author":"Yao","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41557-022-01039-3","article-title":"Synthesis and single-molecule imaging reveal stereospecific enhancement of binding kinetics by the antitumour eEF1A antagonist SR-A3","volume":"14","author":"Wang","year":"2022","journal-title":"Nat. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10145","DOI":"10.1002\/anie.201411377","article-title":"Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative Properties","volume":"54","author":"Hoffmann","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1002\/anie.201505069","article-title":"Nannocystin A: An Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer Properties","volume":"54","author":"Krastel","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105870","DOI":"10.1016\/j.phrs.2021.105870","article-title":"Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo","volume":"173","author":"Hou","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41401-024-01231-w","article-title":"Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1","volume":"45","author":"Zhang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"eaap8307","DOI":"10.1126\/scitranslmed.aap8307","article-title":"Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis","volume":"10","author":"Frankowski","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1021\/acs.jmedchem.2c00204","article-title":"Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis","volume":"65","author":"Frankowski","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1021\/acs.jmedchem.8b00078","article-title":"Identification of Eukaryotic Translation Elongation Factor 1-\u03b1 1 Gamendazole-Binding Site for Binding of 3-Hydroxy-4(1H)-quinolinones as Novel Ligands with Anticancer Activity","volume":"61","author":"Markos","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1021\/acschembio.1c00094","article-title":"Identifying the Cellular Target of Cordyheptapeptide A and Synthetic Derivatives","volume":"16","author":"Klein","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14627","DOI":"10.1002\/anie.201709744","article-title":"Cyclic Depsipeptide BE-43547A2: Synthesis and Activity against Pancreatic Cancer Stem Cells","volume":"56","author":"Sun","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e202206953","DOI":"10.1002\/anie.202206953","article-title":"Probe Synthesis Reveals Eukaryotic Translation Elongation Factor\u20051 Alpha\u20051 as the Anti-Pancreatic Cancer Target of BE-43547A2","volume":"61","author":"Liu","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Losada, A., Munoz-Alonso, M.J., Garcia, C., Sanchez-Murcia, P.A., Martinez-Leal, J.F., Dominguez, J.M., Lillo, M.P., Gago, F., and Galmarini, C.M. (2016). Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin. Sci. Rep., 6.","DOI":"10.1038\/srep35100"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1016\/S0021-9258(17)40692-2","article-title":"GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1\u03b1","volume":"269","author":"Crews","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1038\/sj.onc.1205972","article-title":"Aplidin\u2122 induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C \u03b4","volume":"21","author":"Losada","year":"2002","journal-title":"Oncogene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1074\/jbc.M201010200","article-title":"AplidinTM induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK","volume":"278","author":"Cuadrado","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1038\/sj.onc.1207636","article-title":"JNK activation is critical for Aplidin\u2122-induced apoptosis","volume":"23","author":"Cuadrado","year":"2004","journal-title":"Oncogene"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/sj.cdd.4401898","article-title":"Aplidin\u00ae induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation","volume":"13","author":"Zarich","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_56","first-page":"1535","article-title":"Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas\/CD95-and mitochondrial-mediated mechanism","volume":"9","author":"Gajate","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.1074\/jbc.M411781200","article-title":"Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy","volume":"280","author":"Gajate","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.leu.2402788","article-title":"Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4","volume":"17","author":"Broggini","year":"2003","journal-title":"Leukemia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1038\/sj.bjc.6601864","article-title":"Antiangiogenic activity of aplidine, a new agent of marine origin","volume":"90","author":"Taraboletti","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s10637-011-9740-3","article-title":"The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells","volume":"30","author":"Morande","year":"2012","journal-title":"Investig. New Drugs"},{"key":"ref_61","first-page":"1886","article-title":"Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed\/refractory multiple myeloma","volume":"130","author":"Spicka","year":"2017","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1158\/0008-5472.CAN-07-5725","article-title":"Aplidin, a marine organism\u2013derived compound with potent antimyeloma activity in vitro and in vivo","volume":"68","author":"Mitsiades","year":"2008","journal-title":"Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41416-018-0336-y","article-title":"Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumor cell survival","volume":"119","author":"Losada","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Losada, A., Berlanga, J.J., Molina-Guijarro, J.M., Jimenez-Ruiz, A., Gago, F., Aviles, P., de Haro, C., and Martinez-Leal, J.F. (2020). Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells. Biochem. Pharmacol., 172.","DOI":"10.1016\/j.bcp.2019.113744"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nchembio.1797","article-title":"Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B","volume":"11","author":"Potts","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7164\/antibiotics.50.370","article-title":"Cytotrienin A, a novel apoptosis inducer in human leukemia HL-60 cells","volume":"50","author":"Kakeya","year":"1997","journal-title":"J. Antibiot."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1261\/rna.2307710","article-title":"Inhibition of translation by cytotrienin A--a member of the ansamycin family","volume":"16","author":"Lindqvist","year":"2010","journal-title":"RNA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8766","DOI":"10.1074\/jbc.275.12.8766","article-title":"Activation of MST\/Krs and c-Jun N-terminal kinases by different signaling pathways during cytotrienin A-induced apoptosis","volume":"275","author":"Watabe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_69","first-page":"4888","article-title":"Caspase-mediated activation of a 36-kDa myelin basic protein kinase during anticancer drug-induced apoptosis","volume":"58","author":"Kakeya","year":"1998","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.7164\/antibiotics.35.1460","article-title":"Studies on mycotrienin antibiotics, a novel class of ansamycins I. Taxonomy, fermentation, isolation and properties of mycotrienins I and II","volume":"35","author":"Sugita","year":"1982","journal-title":"J. Antibiot."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ja.2011.23","article-title":"Mycotrienin II, a translation inhibitor that prevents ICAM-1 expression induced by pro-inflammatory cytokines","volume":"64","author":"Yamada","year":"2011","journal-title":"J. Antibiot."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/j.tetlet.2006.04.073","article-title":"(\u2212)-Ternatin, a highly N-methylated cyclic heptapeptide that inhibits fat accumulation: Structure and synthesis","volume":"47","author":"Shimokawa","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e10222","DOI":"10.7554\/eLife.10222","article-title":"Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex","volume":"4","author":"Carelli","year":"2015","journal-title":"Elife"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e81608","DOI":"10.7554\/eLife.81608","article-title":"Didemnin B and ternatin-4 differentially inhibit conformational changes in eEF1A required for aminoacyl-tRNA accommodation into mammalian ribosomes","volume":"11","author":"Juette","year":"2022","journal-title":"Elife"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cell.2022.12.025","article-title":"An E3 ligase network engages GCN1 to promote the degradation of translation factors on stalled ribosomes","volume":"186","author":"Oltion","year":"2023","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"115535","DOI":"10.1016\/j.taap.2021.115535","article-title":"Nannocystin Ax, a natural elongation factor 1\u03b1 inhibitor from Nannocystis sp., suppresses epithelial-mesenchymal transition, adhesion and migration in lung cancer cells","volume":"420","author":"Sun","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1039\/D2MD00393G","article-title":"Site-directed Late-Stage Diversification of Macrocyclic Nannocystins Facilitating Anticancer SAR and Mode of Action Studies","volume":"14","author":"Zhang","year":"2023","journal-title":"RSC Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-022-05638-5","article-title":"Visualization of translation and protein biogenesis at the ER membrane","volume":"614","author":"Gemmer","year":"2023","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Kashyap, V.K., Sharma, B.P., Pandey, D., Singh, A.K., Peasah-Darkwah, G., Singh, B., Roy, K.K., Yallapu, M.M., and Chauhan, S.C. (2024). Small Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis. Cells, 13.","DOI":"10.3390\/cells13242053"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/1087057109343120","article-title":"Automated High-Content Screening for Compounds That Disassemble the Perinucleolar Compartment","volume":"14","author":"Norton","year":"2009","journal-title":"J. Biomol. Screen."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00280-018-3699-0","article-title":"Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D\/+;Tp53R172H\/+ (KPC) mice, a genetically engineered model of pancreatic cancer","volume":"82","author":"Vilimas","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00280-020-04042-y","article-title":"Metabolism and pharmacokinetics characterization of metarrestin in multiple species","volume":"85","author":"Padilha","year":"2020","journal-title":"Cancer Chemother. Pharm."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"104716","DOI":"10.1016\/j.yrtph.2020.104716","article-title":"Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells","volume":"116","author":"Bourdi","year":"2020","journal-title":"Regul. Toxicol. Pharm."},{"key":"ref_84","unstructured":"Jin, J., Kabir, M., Sun, N., and Kaniskan, H.U. (2022). Preparation of Heterobifunctional Compounds as Degraders of eEF1A2. (WO2022159650A1)."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nchem.2657","article-title":"Synthesis of ent-BE-43547A1 reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural products","volume":"9","author":"Villadsen","year":"2017","journal-title":"Nat. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.chembiol.2018.07.010","article-title":"APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells","volume":"25","author":"Jacobsen","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41401-024-01461-y","article-title":"BE-43547A2 exerts hypoxia-selective inhibition on human pancreatic cancer cells through targeting eEF1A1 and disrupting its association with FoxO1","volume":"46","author":"Liu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Qin, Y., Wang, X., Zhao, M., Liu, Y., Hou, H., Wang, T., Pei, Y., Zhang, J., Shen, Z., and Wu, F. (2025). Therapeutic potential of targeting the NEDD4L-eEF1A1 axis in cancer therapy. Acta Biochim. Biophys. Sin.","DOI":"10.3724\/abbs.2025101"},{"key":"ref_89","first-page":"1","article-title":"Knockdown of the EEF1A2 gene reduces lung cancer brain metastasis by downregulating the BCL10\/NF\u03baB pathway","volume":"11","author":"Li","year":"2025","journal-title":"J. Cancer Metastasis Treat."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7331\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:15Z","timestamp":1760033895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":89,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157331"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157331","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}